Skip to content

The Role of Neurofilament Light (NfL) in Patients With Hydrocephalus

The Role of Neurofilament Light (NfL) in Management of Patients With Hydrocephalus: A Pilot Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05399602
Enrollment
41
Registered
2022-06-01
Start date
2023-12-07
Completion date
2025-09-27
Last updated
2025-10-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Brain Damage, General Anesthetics Toxicity, Hydrocephalus

Keywords

Hydrocephalus, Brain biomarkers, Neurofilament Light Chain, General Anesthesia

Brief summary

Neurofilament Light Chain Protein (NfL) has been found by many studies as a sensitive biomarker of neuronal damage from several reasons, e.g. neurodegenerative diseases (Alzheimer's disease, Multiple Sclerosis, etc.), inflamation (HIV) or trauma. Its role as biomarker thus offers a possibility to predict and manage diseases associated with neuronal damage. Therefore our aim is to investigate the changes in level of NfL in hydrocephalus and to find its role in management of treatment in hydrocephalus.

Interventions

DIAGNOSTIC_TESTLumbar puncture

Standardized lumbar puncture in L3/4 or L4/5 in diagnosis of hydrocephalus and CSF sampling (sample 1 in NfL level measurement)

External lumbar drainage placement for assessing responsivity of external derivation of CSF. It is test of responsivity to ventriculo-peritoneal shunt placement

DIAGNOSTIC_TESTLumbar infusion test

Diagnostic test accompanying the first lumbar puncture made as i diagnostic test of hydrocephalus. Based on infusion of saline by 90 mL per hour with measurement of CSF pressure each 1 minute and then count of so-called Rout (index).

Surgical procedure based on implantation a thin catheter into brain lateral ventricle (placed through a burrhole from Kocher point) and connection to prechamber and valve (placed behind the ear under skin) and similar thin catheter pushed under skin of neck, chest and abdomen (where put intraperitoneally).

PROCEDUREGeneral Anesthesia

Standardized combinated general anesthesia with combination of i.v. and inhalated drugs according the protocol. Given by anesthesiologist.

Puncture of prechamber (place behind the ear under the skin) by thin needle and aspiration of 5 mL of CSF (5 days, 1 month a 2 months after surgery)

Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 24 hours prior surgery

Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 24 hours after surgery

Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 5 days after surgery

Blood sampling to get level of NfL from standarized percutaneous vein puncture by thin needle 1 and 2 months after surgery (only in interventional group)

Sponsors

University Hospital Hradec Kralove
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* In group A: * Patients with diagnosed communicating hydrocephalus * MMSE \> 10 points * Absence of any structural laesion on MRI or CT * Accepted Informed consent * In group B: * MMSE \> 10 points * Absence of any structural laesion on MRI or CT * Accepted Informed consent * Elective spinal surgery without affecting dural sac and the spinal cord * Surgery shorter than 120 minutes of lasting the general anesthesia

Exclusion criteria

* Non-communicating hydrocephalus * Structural laesion on MRI or CT (tumour, contusion, aneurysm) * MMSE \< 10 points * Life-expectancy shorter than 1 year * Pre-existing other type of demetia (m. Alzheimer, vascular dementia) * Surgery lasting more than 120 minutes * Blood loss more than 500 ml * Opening of dural sac (liquororhea) * Adverse events during general anestesia: MAP\<60 mm Hg more than 5 minutes, arythmia with need for farmacological treatment

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rate6 monthsTo assess the number of patients recruited in a pilot study. Recruitment rate is one of the predictor of feasibility of a study
Number of changes in valve settings3 months after surgeryTo investigate the number of changes in valve settings according the patient's clinical state based on clinical examination, CT examination or telemetrically measured CSF pressure

Secondary

MeasureTime frameDescription
Correlation between NfL level and patient's clinical state3 months after surgeryTo investigate in group A the correlation between the level of NfL get from CSF and blood sampling and observation in changes in patient's clinical state measured by mini-mental state examination (MMSE), 5-meter-walking test and patient's self-assessment questionare

Other

MeasureTime frameDescription
Influence of general anesthesia on the level of NfL24 hours before procedure (surgery) and 24 hours and 5 days after surgeryIn group B investigate the level of NfL 24 hours before surgery and 24 hours (blood sampling #2) and 5 days after surgery (blood sampling #3) and comparison with standardized NfL level based on literature. Looking for the influence of general anesthesia on brain damage caused and the prepair in predefined time frame.

Countries

Czechia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026